This federal contract award, valued at $13,876.40, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract covers the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialty medication used for diabetes management. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This larger IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current award does not have a set-aside designation, indicating open competition. The contract has a firm fixed-price pricing type and an ultimate completion date of December 17, 2024.
Generated 3/17/25, 9:55 AM